Stock listing
Amylyx Pharmaceuticals, Inc.
Selected listing: AMLX · BOATS · USD · US
Amylyx Pharmaceuticals, Inc. (BOATS:AMLX), Health Technology. Latest release Oct 6, 2026: Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY…
- Ticker
- BOATS:AMLX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. is a public company traded under the ticker AMLX in the American market. Amylyx focuses on developing innovative therapies for neurological diseases.
Latest news from Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
October 6, 2026
Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum
September 23, 2026
Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference
September 8, 2026
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
August 19, 2026
Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock
August 18, 2026
Events
Research Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. company profile
View the public company page for Amylyx Pharmaceuticals, Inc. on 6ix.
Amylyx Pharmaceuticals, Inc. news
Read company news and market updates connected to Amylyx Pharmaceuticals, Inc..
Amylyx Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Amylyx Pharmaceuticals, Inc..